INDICASAT-AIP

What INDICASAT-AIP does

INDICASAT-AIP (Instituto de Investigaciones Científicas y Servicios de Alta Tecnología de Panamá — Asociación de Interés Público) is a non-profit scientific research institute established in 2002 by Panama's National Secretariat for Science, Technology and Innovation (SENACYT) and headquartered in the Ciudad del Saber (City of Knowledge) complex in Panama City. The institute operates seven research centers spanning biodiversity and drug discovery, neuroscience, cellular and molecular biology of disease (CBCMe), clinical research and translational medicine, innovation and technology transfer, bioinformatics, and a bioterio (animal research facility). It serves Panama's public health system, academic institutions, and pharmaceutical and CRO sponsors conducting studies in tropical disease, antimicrobial resistance, oncology, and natural-product drug discovery.

The institute's core scientific assets include ISO/IEC 17025-certified quality control laboratories, at least one granted U.S. patent (a flavonoid composition, 2020), and senior research staff with doctoral and postdoctoral credentials. It runs a joint doctoral training program with Acharya Nagarjuna University in India and has participated in regional consortia including a COVID-19 vaccine research effort. In 2026 it was designated an OAS Center of Excellence, and in 2027 it will host the XIII SLAMTB Meeting, reinforcing its role as a regional anchor for mycobacterial and infectious disease research.

The institute's revenue is generated primarily through government research appropriations (via SENACYT, MINSA, and CSS), competitive scientific grants, sponsored clinical research services delivered to pharmaceutical sponsors and CROs, philanthropic donations, and academic program fees. As a non-profit, it does not pursue equity funding or commercialization in the conventional venture-backed sense; instead, it builds a translational pathway through partnerships such as its technology transfer agreement with Cipac AIP and its leadership of a new national Center of Thought in Biotechnology.

Name

INDICASAT-AIP

Legal name

Instituto de Investigaciones Científicas y Servicios de Alta Tecnología

Website

https://indicasat.org.pa

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

INDICASAT-AIP is a Panama-based non-profit biomedical research institute founded by SENACYT in 2002, operating seven research centers in tropical disease, drug discovery, neuroscience, and clinical research, and serving the country's public health system, academic partners, and pharmaceutical sponsors.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Electronic Data Capture (EDC) Platforms (HLACAOAA)

Keywords

• Biomedical research services
• Clinical trial coordination
• Drug discovery research
• Tropical disease research
• Pharmaceutical quality testing

Headquarters

HQ city

Panama City

HQ country

Panama

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Government Research Funding: Primary funding from SENACYT (National Secretariat for Science, Technology and Innovation) and government research grants
2. Clinical Research Services: Fee-for-service clinical trial coordination, laboratory testing, and contract research services for pharmaceutical companies and CROs
3. Donations: Tax-deductible donations from individuals and organizations supporting scientific research and education
4. Academic Programs: Doctoral program collaborations with international universities (e.g., Acharya Nagarjuna University partnership)

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

INDICASAT-AIP is a Panamanian non-profit biomedical research institute operating a network of specialized research centers that deliver contract research, laboratory testing, and clinical trial services. It conducts drug discovery from natural biodiversity, Phase 1-4 clinical trials, pharmaceutical quality control testing under ISO/IEC 17025 standards, and graduate training in biomedical and biotechnology research. Services are delivered to government health agencies, pharmaceutical sponsors, CROs, and academic collaborators.

Product overview

INDICASAT-AIP (Instituto de Investigaciones Científicas y Servicios de Alta Tecnología) is a Panamanian scientific research institute established in 2002 by SENACYT. Rather than a single commercial product, it operates as a multi-disciplinary research organization offering scientific research services through its network of specialized centers. The portfolio includes research centers focused on biodiversity and drug discovery, neuroscience, cellular and molecular biology, clinical research, bioinformatics, and technology transfer. The institute also provides laboratory services including pharmaceutical quality control testing and operates graduate academic programs in biomedical research and biotechnology. INDICASAT-AIP functions as a platform for scientific advancement and technology transfer rather than a traditional product company.

Differentiator

Problem solved

Functional benefit

Products and services

• Centro de Biodiversidad y Descubrimiento de Drogas (Biodiversity and Drug Discovery Center)

Quantifiable outcome

• Led Panama's COVID-19 vaccine research consortium and produced critical diagnostic reagents locally during global shortages
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered flagship, core, minor and moderate.

• COVID-19 Vaccine Research Consortium PanamaflagshipStrategic or Co-development Partner · 1 January 2020Led by INDICASAT-AIP, this consortium combined clinical research capabilities to conduct COVID-19 vaccine studies in Panama, leveraging the experience and quality of two leading clinical research organizations for vaccine development against COVID-19.
• SENACYT (Secretaría Nacional de Ciencia, Tecnología e Innovación)coreStrategic or Co-development Partner · 1 January 2002SENACYT created INDICASAT-AIP in 2002 as Panama's flagship research institute for biomedical science. SENACYT provides ongoing government funding and strategic direction for the institute's research agenda, establishing it as the platform for scientific and technological advancement in Panama.
• Ciudad del Saber (City of Knowledge)coreStrategic or Co-development PartnerINDICASAT-AIP is physically located in Building 208 of Ciudad del Saber, Panama's science and technology park. This ecosystem houses multiple research organizations and facilitates cross-institutional collaboration and knowledge sharing among member organizations.
• Acharya Nagarjuna UniversitycoreStrategic or Co-development PartnerJoint doctoral program in Biotechnology between INDICASAT-AIP and Acharya Nagarjuna University in India, enabling international academic collaboration and graduate education in biomedical sciences.
• Cipac AIPminorStrategic or Co-development PartnerCollaboration agreement signed between INDICASAT-AIP and Cipac AIP for joint initiatives in technology transfer and innovation development.
• UK Embassy and International Science PartnersmoderateStrategic or Co-development PartnerOfficial visits and cooperation discussions with UK Ambassador to strengthen bioeconomy and science collaboration, indicating growing international scientific partnerships.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Institut Pasteur: Global network of biomedical research institutes with deep tropical disease focus and historical role as the model for research institutes in developing countries. Comparable institutional mission but operates at significantly larger scale internationally.
• National Institutes of Health (NIH): The world's largest biomedical research agency. Sets the global benchmark for government-affiliated research institutes, though far larger and broader in scope than INDICASAT-AIP, and serves as an upstream funder rather than a direct competitor.
• Wellcome Trust: Major global biomedical research funding and operating organization with a portfolio of research institutes and international science programs. Comparable as a research-funding and capacity-building institution though operates as a foundation rather than an in-country institute.
• Karolinska Institutet: Leading European biomedical research university with extensive international research collaborations. Comparable as a multi-disciplinary biomedical research and doctoral training institution, though at much larger scale and with broader global reach.

Direct peers

• Instituto Butantan: One of the largest biomedical research institutes in Latin America, focused on vaccine development, drug discovery, and clinical research. Comparable as a multi-disciplinary, government-affiliated biomedical research institute with end-to-end discovery-to-clinical capabilities.
• CONICET: Argentina's national research council coordinating multi-disciplinary scientific research and graduate training across institutes. Comparable as a government-affiliated research umbrella with doctoral programs and similar center-based structure.
• Fiocruz: Brazil's flagship biomedical research foundation operating under the Ministry of Health. Closely comparable multi-center, government-affiliated model with clinical research, public health surveillance, vaccine production, and graduate training programs.
• INSP Mexico (Instituto Nacional de Salud Pública): Mexican national public health research institute. Similar Latin American public health research mandate, government affiliation, and focus on epidemiological surveillance, health policy, and laboratory-based research.
• Gorgas Memorial Institute of Health Studies: Panama's other major public health and biomedical research institute. Shares the same government-affiliated non-profit structure, tropical disease research focus, and Panama-based operations, making it the closest functional peer to INDICASAT-AIP.
• Instituto Nacional de Salud (Colombia): Colombian national health institute focused on epidemiological surveillance, public health research, and laboratory testing. Similar mission in tropical disease research and government-affiliated laboratory services in Latin America.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/indicasat-aip

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INDICASAT-AIP